Characterization of the estrogenic activities of zearalenone and zeranol in vivo and in vitro

Journal of Steroid Biochemistry and Molecular Biology

Volumn 103, Issue 2, 2007, Pages 170-177

  Takemura, Hitomi ^a   Shim, Joong Youn ^b   Sayama, Kazutoshi ^c   Tsubura, Airo ^d   Zhu, Bao Ting ^e   Shimoi, Kayoko ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

^c SHIZUOKA UNIVERSITY   (Japan)

^d KANSAI MEDICAL UNIVERSITY   (Japan)

^e UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Human estrogen receptor and ; Radioligand receptor binding assay; Uterotropic assay; Zearalenone; Zeranol

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ZEARALENONE; ZERANOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CRYSTAL STRUCTURE; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG POTENCY; ESTROGEN ACTIVITY; FEMALE; HORMONE DETERMINATION; HORMONE RECEPTOR INTERACTION; HORMONE STRUCTURE; HUMAN; IC 50; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR MODEL; MOUSE; NONHUMAN; RECEPTOR BINDING; UTERUS WEIGHT; X RAY CRYSTALLOGRAPHY;

ANIMALS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS, NON-STEROIDAL; FEMALE; HUMANS; MICE; MICE, INBRED ICR; MODELS, BIOLOGICAL; MODELS, MOLECULAR; OVARIECTOMY; PROTEIN BINDING; ZEARALENONE; ZERANOL;

MUS;

EID: 33846409114     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2006.08.008     Document Type: Article

References (23)

1. Abid-Essefi S., Ouanes Z., Hassen W., Baudrimont I., Creppy E., and Bacha H. Cytotoxicity, inhibition of DNA and protein syntheses and oxidative damage in cultured cells exposed to zearalenone. Toxicol. In Vitro 18 (2004) 467-474
2. Ruddick J.A., Scott P.M., and Harwig J. Teratological evaluation of zearalenone administered orally to the rat. Bull. Environ. Contam. Toxicol. 15 (1976) 678-681
3. Ghedira-Chekir L., Maaroufi K., Creppy E.E., and Bacha H. Cytotoxic and genotoxic effects of zearalenone: prevention by vitamin E. J. Toxicol. Toxin Rev. 18 (1999) 355-368
4. Peters C.A. Photochemistry of zearalenone and its derivatives. J. Med. Chem. 15 (1972) 867-868
5. Sheehan D.M., Branham W.S., Medlock K.L., and Shanmugasundaram E.R. Estrogenic activity of zearalenone and zearalanol in the neonatal rat uterus. Teratology 29 (1984) 383-392
6. Jefferson W.N., Padilla-Banks E., Clark G., and Newbold R.R. Assessing estrogenic activity of phytochemicals using transcriptional activation and immature mouse uterotrophic responses. J. Chromatogr. 25 (2002) 179-189
7. Greenman D.L., Mehta R.G., and Wittliff J.L. Nuclear interaction of Fusarium mycotoxins with estradiol binding sites in the mouse uterus. J. Toxicol. Environ. Health 5 (1979) 593-598
8. Shier W.T., Shier A.C., Xie W., and Mirocha C.J. Structure-activity relationships for human estrogenic activity in zearalenone mycotoxins. Toxicon 39 (2001) 1435-1438
9. Le-Guevel R., and Pakdel F. Assessment of oestrogenic potency of chemicals used as growth promoter by in-vitro methods. Hum. Reprod. 16 (2001) 1030-1036
10. Bovee T.F., Helsdingen R.J., Rietjens I.M., Keijer J., and Hoogenboom R.L. Rapid yeast estrogen bioassays stably expressing human estrogen receptors α and β, and green fluorescent protein: a comparison of different compounds with both receptor types. J. Steroid Biochem. Mol. Biol. 91 (2004) 99-109
11. Liu Z.J., and Zhu B.T. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells. J. Steroid Biochem. Mol. Biol. 88 (2004) 265-275
12. Takemura H., Ma J., Sayama K., Terao Y., Zhu B.T., and Shimoi K. In vitro and in vivo estrogenic activity of chlorinated derivatives of bisphenol A. Toxicology 207 (2005) 215-221
13. Shiau A.K., Barstad D., Loria P.M., Cheng L., Kushner P.J., Agard D.A., and Greene G.L. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95 (1998) 927-937
14. Malamas M.S., Manas E.S., McDevitt R.E., Gunawan I., Xu Z.B., Collini M.D., Miller C.P., Dinh T., Henderson R.A., Keith Jr. J.C., and Harris H.A. Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands. J. Med. Chem. 47 (2004) 5021-5040
15. Brzozowski A.M., Pike A.C., Dauter Z., Hubbard R.E., Bonn T., Engstrom O., Ohman L., Greene G.L., Gustafsson J.A., and Carlquist M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389 (1997) 753-758
16. Press W.H., Teukolsky S.A., Vetterling W.T., and Flanery B.P. Numerical Recipes-The Art of Scientific Computing (1993), Cambridge Univ. Press, Cambridge pp. 420-424
17. von der Lieth C.W., and Kozar T. Towards a better semiquantitative estimation of binding constants:molecular dynamics exploration of the conformational behaviour of isolated sialyllactose and sialyllactose complexed with influenza A hemagglutinin. J. Mol. Struct. (THEOCHEM) 368 (1996) 213-222
18. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., van der Burg B., and Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139 (1998) 4252-4263
19. Mehmood Z., Smith A.G., Tucker M.J., Chuzel F., and Carmichael N.G. The development of methods for assessing the in vivo oestrogen-like effects of xenobiotics in CD-1 mice. Food Chem. Toxicol. 38 (2000) 493-501
20. Kuiper G.G., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., and Gustafsson J.A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138 (1997) 863-870
21. Couse J.F., Lindzey J., Grandien K., Gustafsson J., and Korach K.S. Tissue distribution and quantitative analysis of estrogen receptor-α (ERα) and estrogen receptor-β (ERβ) messenger ribonucleic acid in the wild-type and ERα-knockout mouse. Endocrinology 138 (1997) 4613-4621
22. Weihua Z., Saji S., Makinen S., Cheng G., Jensen E.V., Warner M., and Gustafsson J.A. Estrogen receptor (ER) β, a modulator of ERα in the uterus. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 5936-5941
23. Aliau S., Mattras H., Richard E., Bonnafous J.C., and Borgna J.L. Differential interactions of estrogens and antiestrogens at the 17 beta-hydroxyl or counterpart hydroxyl with histidine 524 of the human estrogen receptor alpha. Biochemistry 41 (2002) 7979-7988